Adaptive Biotechnologies Corp. (ADPT) on GreekSoup https://greeksoup.ai/stocks/us/adpt/ Every dated entry in the public record on Adaptive Biotechnologies Corp.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Wed, 28 Oct 2026 00:00:00 +0000 Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 8,503 shares (under a trading plan set in advance) at $25.94 on 26 October 2026, $220,568https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-26:84545eb224Mon, 26 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 3,378 shares (under a trading plan set in advance) at $26.30 on 26 October 2026, $88,841https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-26:d4b4c047aaMon, 26 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 4,500 shares (under a trading plan set in advance) at $24.50 on 23 October 2026, $110,250https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-26:3b1da442dfMon, 26 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 7,381 shares (under a trading plan set in advance) at $25.28 on 23 October 2026, $186,592https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-26:19ceb9ab4aMon, 26 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 10,181 shares (under a trading plan set in advance) at $24.38 on 22 October 2026, $248,213https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-26:6b82978087Mon, 26 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 1,700 shares (under a trading plan set in advance) at $25.29 on 22 October 2026, $42,993https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-26:5f8cb98732Mon, 26 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 5,999 shares (under a trading plan set in advance) at $25.25 on 21 October 2026, $151,475https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-21:5318abf790Wed, 21 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 5,882 shares (under a trading plan set in advance) at $25.57 on 21 October 2026, $150,403https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-21:8c3eecf8adWed, 21 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 11,781 shares (under a trading plan set in advance) at $24.53 on 20 October 2026, $288,988https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-21:55f24f9787Wed, 21 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 100 shares (under a trading plan set in advance) at $24.85 on 20 October 2026, $2,485https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-21:eae896c5baWed, 21 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 11,881 shares (under a trading plan set in advance) at $24.05 on 19 October 2026, $285,738https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-21:036e406187Wed, 21 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 11,581 shares (under a trading plan set in advance) at $24.21 on 16 October 2026, $280,376https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-16:802d9c829dFri, 16 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 300 shares (under a trading plan set in advance) at $25.45 on 16 October 2026, $7,635https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-16:f999b9e943Fri, 16 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 11,881 shares (under a trading plan set in advance) at $25.61 on 15 October 2026, $304,272https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-16:417282b65cFri, 16 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 6,781 shares (under a trading plan set in advance) at $25.57 on 14 October 2026, $173,390https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-16:1f9a4c3b26Fri, 16 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 5,100 shares (under a trading plan set in advance) at $25.82 on 14 October 2026, $131,682https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-16:37a9926dadFri, 16 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: short interest 11,991,988 shares at the 15 October 2026 settlement, 5.03 days to coverhttps://greeksoup.ai/stocks/us/adpt/short-interest/us:ADPT:short-interest:2026-10-15:3e677d9415Thu, 15 Oct 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 11,881 shares (under a trading plan set in advance) at $25.50 on 13 October 2026, $302,966https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-13:95f30e0be1Tue, 13 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 9,181 shares (under a trading plan set in advance) at $25.35 on 12 October 2026, $232,738https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-13:cbacea2cfeTue, 13 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 2,700 shares (under a trading plan set in advance) at $26.07 on 12 October 2026, $70,389https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-13:8beb4b1f32Tue, 13 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 11,881 shares (under a trading plan set in advance) at $26.41 on 9 October 2026, $313,777https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-13:341d9fdc8aTue, 13 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 11,881 shares (under a trading plan set in advance) at $25.66 on 8 October 2026, $304,866https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-08:fcb81849b3Thu, 08 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 11,881 shares (under a trading plan set in advance) at $26.40 on 7 October 2026, $313,658https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-08:56682364edThu, 08 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 9,381 shares (under a trading plan set in advance) at $27.36 on 6 October 2026, $256,664https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-08:0f66bbabfeThu, 08 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 1,100 shares (under a trading plan set in advance) at $28.21 on 6 October 2026, $31,031https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-08:d7bb8f18bbThu, 08 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 901 shares (under a trading plan set in advance) at $29.71 on 6 October 2026, $26,769https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-08:37b82e1933Thu, 08 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 499 shares (under a trading plan set in advance) at $30.53 on 6 October 2026, $15,234https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-08:8bfd7f029cThu, 08 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Bobulsky Susan (Chief Commercial Officer, MRD) sold 6,444 shares (under a trading plan set in advance) at $30.00 on 6 October 2026, $193,320https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-08:ee1ae0706bThu, 08 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, SUSAN BOBULSKY plans to sell 6,444 shares worth $192,289 around 6 October 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-10-06:e228e7f16bTue, 06 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 6,699 shares (under a trading plan set in advance) at $28.82 on 5 October 2026, $193,065https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-05:3c5f1f607aMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 5,182 shares (under a trading plan set in advance) at $29.67 on 5 October 2026, $153,750https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-05:647696f3e5Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 11,881 shares (under a trading plan set in advance) at $28.13 on 2 October 2026, $334,213https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-05:3bac992597Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 6,081 shares (under a trading plan set in advance) at $27.57 on 1 October 2026, $167,653https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-05:03060161fbMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Rubinstein Julie (President and COO) sold 5,800 shares (under a trading plan set in advance) at $28.56 on 1 October 2026, $165,648https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-05:09e4956888Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Lo Francis (Chief People Officer) sold 8,094 shares (under a trading plan set in advance) at $27.52 on 1 October 2026, $222,747https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-05:dec0ba4fbcMon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Lo Francis (Chief People Officer) sold 18,698 shares (under a trading plan set in advance) at $28.61 on 1 October 2026, $534,950https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-10-05:238bc03cf5Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, JULIE RUBINSTEIN plans to sell 379,777 shares worth $11.0 million around 1 October 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-10-01:daa6bdb7d0Thu, 01 Oct 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: short interest 11,843,887 shares at the 30 September 2026 settlement, 4.43 days to coverhttps://greeksoup.ai/stocks/us/adpt/short-interest/us:ADPT:short-interest:2026-09-30:6bade4e615Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Lo Francis (Chief People Officer) sold 107,537 shares (under a trading plan set in advance) at $28.02 on 16 September 2026, $3.0 millionhttps://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-09-18:9c98e553f5Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Lo Francis (Chief People Officer) sold 7,869 shares (under a trading plan set in advance) at $28.57 on 16 September 2026, $224,817https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-09-18:dbaf9ce5c8Fri, 18 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Bobulsky Susan (Chief Commercial Officer, MRD) sold 1,195 shares (under a trading plan set in advance) at $27.00 on 15 September 2026, $32,265https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-09-17:e79f3b0766Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, FRANCIS LO plans to sell 142,198 shares worth $3.8 million around 16 September 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-09-16:520c92e362Wed, 16 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, SUSAN BOBULSKY plans to sell 1,195 shares worth $29,612 around 15 September 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-09-15:d35ca6ac65Tue, 15 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: short interest 13,489,581 shares at the 15 September 2026 settlement, 7.89 days to coverhttps://greeksoup.ai/stocks/us/adpt/short-interest/us:ADPT:short-interest:2026-09-15:bc1becf154Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: short interest 11,712,796 shares at the 31 August 2026 settlement, 6.37 days to coverhttps://greeksoup.ai/stocks/us/adpt/short-interest/us:ADPT:short-interest:2026-08-31:aa3f34e9f6Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Owen Katey Einterz (Director) sold 9,615 shares at $26.00 on 26 August 2026, $249,990https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-08-28:2dcd3aeeb9Fri, 28 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, KATHERINE E OWEN plans to sell 9,615 shares worth $249,990 around 26 August 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-08-26:ed6e232edcWed, 26 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, Harlan Robins plans to sell 402,160 shares worth $10.2 million around 20 August 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-08-20:7483b66cdeThu, 20 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Hershberg Robert (Director) sold 15,000 shares at $24.39 on 18 August 2026, $365,850https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-08-20:e2485b4438Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Hershberg Robert (Director) sold 15,664 shares at $24.41 on 18 August 2026, $382,358https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-08-20:4dccd60ed5Thu, 20 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, Harlan Robins plans to sell 215,632 shares worth $5.5 million around 19 August 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-08-19:94709dcd80Wed, 19 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Robins Chad M (CEO and Chairman) sold 278,472 shares at $24.48 on 18 August 2026, $6.8 millionhttps://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-08-19:1db3ad654bWed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Robins Chad M (CEO and Chairman) sold 204 shares at $25.14 on 18 August 2026, $5,129https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-08-19:29db44b850Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Robins Chad M (CEO and Chairman) sold 318,799 shares at $25.08 on 17 August 2026, $8.0 millionhttps://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-08-19:9a60470f0aWed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Robins Chad M (CEO and Chairman) sold 2,525 shares at $25.57 on 17 August 2026, $64,564https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-08-19:078637279cWed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Neupert Peter M (Director) sold 15,000 shares at $25.23 on 17 August 2026, $378,450https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-08-19:df587d2e63Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Neupert Peter M (Director) sold 40,000 shares at $25.10 on 17 August 2026, $1.0 millionhttps://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-08-19:866e612c2dWed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Neupert Peter M (Director) sold 69,690 shares at $25.16 on 17 August 2026, $1.8 millionhttps://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-08-19:40aac50255Wed, 19 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, ROBERT M HERSHBERG plans to sell 30,664 shares worth $748,303 around 18 August 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-08-18:4a271064b5Tue, 18 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, Harlan Robins plans to sell 261,044 shares worth $6.4 million around 18 August 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-08-18:dfc682ad46Tue, 18 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, Chad Robins plans to sell 278,676 shares worth $6.8 million around 18 August 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-08-18:cefddd710eTue, 18 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, PETER NEUPERT plans to sell 124,690 shares worth $3.1 million around 17 August 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-08-17:3de4470991Mon, 17 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, Harlan Robins plans to sell 300,992 shares worth $7.5 million around 17 August 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-08-17:90ee503365Mon, 17 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, Chad Robins plans to sell 321,324 shares worth $8.0 million around 17 August 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-08-17:2f00790c08Mon, 17 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: short interest 13,323,767 shares at the 14 August 2026 settlement, 5.72 days to coverhttps://greeksoup.ai/stocks/us/adpt/short-interest/us:ADPT:short-interest:2026-08-14:c2653c7ccbFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Bobulsky Susan (Chief Commercial Officer, MRD) sold 3,000 shares (under a trading plan set in advance) at $25.00 on 10 August 2026, $75,000https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-08-12:9d0f164bcdWed, 12 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, SUSAN BOBULSKY plans to sell 3,000 shares worth $74,790 around 10 August 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-08-10:0e7f6a2032Mon, 10 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp. Q2 FY2026 results: revenue $72 million, net income -$40 millionhttps://greeksoup.ai/stocks/us/adpt/results/fy2026-q2/us:ADPT:result:2026-08-04:0795644a5aTue, 04 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/adpt/filings/us:ADPT:filing:2026-08-04:db01091230Tue, 04 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Bobulsky Susan (Chief Commercial Officer, MRD) sold 1,299 shares (under a trading plan set in advance) at $24.00 on 30 July 2026, $31,176https://greeksoup.ai/stocks/us/adpt/insiders/us:ADPT:insider:2026-08-03:566839af3aMon, 03 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: short interest 12,490,395 shares at the 31 July 2026 settlement, 4.39 days to coverhttps://greeksoup.ai/stocks/us/adpt/short-interest/us:ADPT:short-interest:2026-07-31:2b5dc3edf9Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Adaptive Biotechnologies Corp.: Form 144, SUSAN BOBULSKY plans to sell 1,299 shares worth $29,305 around 30 July 2026https://greeksoup.ai/stocks/us/adpt/planned-sales/us:ADPT:planned-sale:2026-07-30:56007bad68Thu, 30 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]>